newsfilter
← Latest News
GlobeNewswire·

Galera Announces Plan to Submit Avasopasem NDA by Year End

MALVERN, Pa., May 16, 2022 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (NASDAQ:GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transf